Toggle navigation
Home
Search
Services
Blog
Contact
About
New Therapeutic Targets for the Treatment of Neurodegenerative Disease, Diabetes
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Maternal Traumatic Stress and Child Development: Epigenetic Links
Wnt/beta-catenin signaling in exocrine pancreas developoment and regeneration
Low-Cost High-Temperature Superconducting Magnetic Resonance Imaging System
Stat3 in Post-Ischemic Myocardial Inflammation
Transferrin Receptor and Erythropoiesis
Recently added grants:
Precision guided SIT for the control of vector-borne disease
GP130/STAT3 signalling in articular cartilage development and regeneration
Investigating the Neural Circuits of Itch
GSK3 beta study in patients with Myotonic Dystrophy 1
Mechanistic Studies of the Natural Product Nicotinamide Riboside for Relief of Painful Sensory Neuropathy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research and Development Contracts (N01)
Project #
N01AG31009-4-0-1
Application #
7714271
Study Section
Project Start
2003-09-30
Project End
2007-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
$110,974
Indirect Cost
Related projects
NIH 2007
N01 AG
New Therapeutic Targets for the Treatment of Neurodegenerative Disease, Diabetes
Tanga, Mary /
$110,974
NIH 2007
N01 AG
New Therapeutic Targets for the Treatment of Neurodegenerative Disease, Diabetes
/
$110,974
Comments
Be the first to comment on this grant